← Leaderboards
Aaiyappa M Palecanda
Ligocyte Pharmaceuticals, Inc.
$728,648
Attributed
$728,648
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$728,648 · 1
By mechanism
R43$728,648 · 1
Top collaborators
No co-investigators on record.
Most similar at Ligocyte Pharmaceuticals, Inc.
Same institution · by research overlap
- Susan Wimer$4,698,162
Others in their field
Top investigators on “Enzyme Linked Immunosorbent Assay”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,730,646
- Philip Louis Felgner · Gene Therapy Systems, Inc.$41,441,562
- Marianne Ward · Duke University$21,475,073
- Andrew B Norman · University Of Cincinnati$21,321,632
- Eric S. Orwoll · Oregon Health And Science University$20,906,524
- Andrew E. Levin · Immunetics, Inc.$20,730,152
Research focus
Enzyme Linked Immunosorbent AssayTechnology /Technique DevelopmentBioterrorism /Chemical WarfareMonoclonal AntibodyBacillus AnthracisBiomimeticsMicroorganism ImmunologyPassive ImmunizationPeptide LibraryPeptidesPhage DisplayPhagocytosisRespiratory InfectionsSporesVaccine DevelopmentAlveolar MacrophagesWestern BlottingsAnthrax ToxinAnthrax VaccinesAntibacterial Antibody